There are currently no events to display.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings.
ACRX (Common Stock)
Data provided by Nasdaq. Minimum 15 minutes delayed.
08/03/20Aug032020 Summary ToggleAcelRx to Host Second Quarter 2020 Financial Results Call and Webcast on Monday, August 10th, 2020
07/23/20Jul232020 Summary ToggleAcelRx Announces Exclusive Distribution and Promotion Partnership for DSUVIA®
07/23/20Jul232020 Summary ToggleAcelRx Announces $10 Million Common Stock Offering Priced At The Market
July 2020 Corporate Presentation
Analyst Day Presentation